Absorption and metabolism of nafarelin, a potent agonist of gonadotropin-releasing hormone
- 1 September 1988
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 44 (3) , 275-282
- https://doi.org/10.1038/clpt.1988.150
Abstract
Nafarelin, a potent gonadotropin-releasing hormone (GnRH) agonist, was absorbed rapidly into systemic circulation (time to reach peak concentration, 20 to 40 minutes) after intranasal but not after sublingual or vaginal administration. Serum elimination half-life was about 2 hours. Nasal absorption of nafarelin was increased by increasing the concentration of the drug in the dose solution and incorporating sodium glycocholate into the nasal formulation. An optimal formulation providing maximum nasal absorption of nafareline was one containing 1.75 mg nafarelin per ml and 2% sodium glycocholate. Bioavailability of this nasal formulation relative to a single subcutaneous dose averaged 21%. The metabolism and excretion of nafarelin were determined in three subjects after subcutaneous administration of [14C]-nafarelin. Radioactivity was excreted in approximately equal amounts in urine and stool. Six metabolites accounted for most of the radioactivity in urine. Four metabolites were short peptide fragments of nafarelin and the other metabolites were naphythylalanine and 2-naphthylacetic acid.This publication has 22 references indexed in Scilit:
- Radioimmunoassay of nafarelin ([6-(3-(2-naphthyl)-d-alanine)]-luteinizing hormone-releasing hormone) in plasma or serumAnalytical Biochemistry, 1984
- The Stimulatory and Down-Regulatory Effects of a Gonadotropin-Releasing Hormone Agonist in Man*Journal of Clinical Endocrinology & Metabolism, 1984
- HORMONAL EFFECTS OF GnRH AGONIST IN THE HUMAN MALE: II. TESTOSTERONE ENHANCES GONADOTROPHIN SUPPRESSION INDUCED BY GnRH AGONISTClinical Endocrinology, 1984
- Synthesis and biological activity of some very hydrophobic superagonist analogs of luteinizing hormone-releasing hormoneJournal of Medicinal Chemistry, 1982
- Substrate specificity of an adenohypophyseal endopeptidase capable of hydrolyzing luteinizing hormone-releasing hormone: preferential cleavage of peptide bonds involving the carboxyl terminus of hydrophobic and basic amino acidsBiochemistry, 1982
- Purification and Properties of a Bovine Brain Thyrotropin‐Releasing‐Factor DeamidaseEuropean Journal of Biochemistry, 1981
- An approach to the elucidation of metabolic breakdown products of the luteinizing hormone-releasing hormoneJournal of Medicinal Chemistry, 1981
- Characterization of a nonchymotrypsin-like endopeptidase from anterior pituitary that hydrolyzes luteinizing hormone-releasing hormone at the tyrosyl-glycine and histidyl-tryptophan bondsBiochemistry, 1980
- Characterization of “thyroliberin-deamidating enzyme” as a post-proline-cleaving enzyme. Partial purification and enzyme-chemical analysis of the enzyme from anterior pituitary tissue.Journal of Biological Chemistry, 1979
- The Two-Period Change-Over Design and Its Use in Clinical TrialsPublished by JSTOR ,1965